Your browser doesn't support javascript.
loading
Development of potency, breadth and resilience to viral escape mutations in SARS-CoV-2 neutralizing antibodies
Frauke Muecksch; Yiska Weisblum; Christopher Barnes; Fabian Schmidt; Dennis Schaefer-Babajew; Julio Lorenzi; Andrew Flyak; Andrew DeLaitsch; Kathryn Huey-Tubman; Shurong Hou; Celia Schiffer; Christian Gaebler; Zijun Wang; Justin Da Silva; Daniel Poston; Shlomo Finkin; Alice Cho; Melissa Cipolla; Thiago Oliveira; Katrina Millard; Victor Ramos; Anna Gazumyan; Magdalena Rutkowska; Marina Caskey; Michel Nussenzweig; Pamela Bjorkman; Theodora Hatziioannou; Paul Bieniasz.
Affiliation
  • Frauke Muecksch; The Rockefeller University
  • Yiska Weisblum; The Rockefeller University
  • Christopher Barnes; California Institute of Technology
  • Fabian Schmidt; The Rockefeller University
  • Dennis Schaefer-Babajew; The Rockefeller University
  • Julio Lorenzi; The Rockefeller University
  • Andrew Flyak; California Institute of Technology
  • Andrew DeLaitsch; California Institute of Technology
  • Kathryn Huey-Tubman; California Institute of Technology
  • Shurong Hou; Unversity Of Massachussets Medical School
  • Celia Schiffer; Unversity Of Massachussets Medical School
  • Christian Gaebler; The Rockefeller University
  • Zijun Wang; The Rockefeller University
  • Justin Da Silva; The Rockefeller University
  • Daniel Poston; The Rockefeller University
  • Shlomo Finkin; The Rockefeller University
  • Alice Cho; The Rockefeller University
  • Melissa Cipolla; The Rockefeller University
  • Thiago Oliveira; The Rockefeller University
  • Katrina Millard; The Rockefeller University
  • Victor Ramos; The Rockefeller University
  • Anna Gazumyan; The Rockefeller University
  • Magdalena Rutkowska; The Rockefeller University
  • Marina Caskey; The Rockefeller University
  • Michel Nussenzweig; The Rockefeller University
  • Pamela Bjorkman; California Institute of Technology
  • Theodora Hatziioannou; The Rockefeller University
  • Paul Bieniasz; The Rockefeller University
Preprint in English | bioRxiv | ID: ppbiorxiv-434227
ABSTRACT
Antibodies elicited in response to infection undergo somatic mutation in germinal centers that can result in higher affinity for the cognate antigen. To determine the effects of somatic mutation on the properties of SARS-CoV-2 spike receptor-binding domain (RBD)-specific antibodies, we analyzed six independent antibody lineages. As well as increased neutralization potency, antibody evolution changed pathways for acquisition of resistance and, in some cases, restricted the range of neutralization escape options. For some antibodies, maturation apparently imposed a requirement for multiple spike mutations to enable escape. For certain antibody lineages, maturation enabled neutralization of circulating SARS-CoV-2 variants of concern and heterologous sarbecoviruses. Antibody-antigen structures revealed that these properties resulted from substitutions that allowed additional variability at the interface with the RBD. These findings suggest that increasing antibody diversity through prolonged or repeated antigen exposure may improve protection against diversifying SARS-CoV-2 populations, and perhaps against other pandemic threat coronaviruses.
License
cc_by_nc_nd
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2021 Document type: Preprint
Full text: Available Collection: Preprints Database: bioRxiv Language: English Year: 2021 Document type: Preprint
...